Edition:
United States

Reata Pharmaceuticals Inc (RETA.O)

RETA.O on Consolidated Issue listed on NASDAQ Global Market

85.87USD
17 Jul 2019
Change (% chg)

$-1.08 (-1.24%)
Prev Close
$86.95
Open
$86.96
Day's High
$87.10
Day's Low
$85.87
Volume
23,212
Avg. Vol
230,057
52-wk High
$104.53
52-wk Low
$42.01

About

Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing product candidates that modulate the activity of regulatory proteins involved in the biology of mitochondrial function, oxidative stress, and inflammation to address the unmet medical... (more)

Overall

Beta: --
Market Cap(Mil.): $832.70
Shares Outstanding(Mil.): 26.10
Dividend: --
Yield (%): --

Financials

  RETA.O Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -1.06 -- --
ROI: -63.77 8.96 14.49
ROE: -- 10.09 15.79

Earnings vs. Estimates